clinical considerations for anthrax in pregnant and postpartum women
DESCRIPTION
Clinical Considerations for Anthrax in Pregnant and Postpartum Women. Dana Meaney-Delman, MD MPH Assistant Professor of Gynecology and Obstetrics Emory University School of Medicine Consultant Division of Reproductive Health Centers for Disease Control and Prevention. Overview. - PowerPoint PPT PresentationTRANSCRIPT
Clinical Considerations for Anthrax in Pregnant and Postpartum Women
Dana Meaney-Delman, MD MPHAssistant Professor of Gynecology and ObstetricsEmory University School of MedicineConsultantDivision of Reproductive HealthCenters for Disease Control and Prevention
Overview• Review unique features of
pregnant women
• Comprehensive review of reported clinical experience with anthrax in pregnancy and the postpartum period
Pregnant and Postpartum Women
Approximately 7 million pregnancies/year Population that is not well studied
Recent H1N1 pandemic experience Complex clinical management decisions Pre-event planning essential to ensure an
efficient public health response and minimize the burden of disease
Ventura et al. National Vital Statistics Report 2009: 58(4): 1-13Cono et al. Emerg Infect Dis 2006;12:11 1631-1637.Pandemic and All-Hazards Preparedness Act. Public Law 109-417. December 19, 2006.
Considerations for Infectious Disease in Pregnancy
Maternal• Susceptibility• Severity• Obstetrical Issues• Access to
appropriate treatment
• Adherence
Fetal• Complications from
maternal infection• Congenital
infection• Risks from
diagnostic testing and treatments
Major Physiologic Characteristics of Pregnancy
Organ System Physiologic ChangeImmunologic shift away from cell-mediated immunity
and toward humoral immunityRespiratory increased tidal volume
decreased maternal oxygen reservedecreased lung compliance
Cardiovascular increased blood volumedecreased intravascular oncotic pressureincreased volume of distribution
Gastrointestinal decreased function and motilityRenal increased glomerular filtration
Increased renal secretionJamieson et al. Emerg Infect Dis ; 2006: 12:11Cono et al. Emerg Infect Dis; 2006: 12:11
Choice of Antimicrobial Agents in Pregnancy
Efficacy of drug Pharmacokinetics Maternal risks Fetal risks Other concerns
Availability Tolerability Adherence
Cono et al. Emerging Infectious Diseases; 2006: 12:11 1631-1637 Lagoy et al. J Women’s Health;2005:14: 104-110
What do we know about anthrax in
pregnancy?
Systematic Review of Worldwide Experience
• Extensive search dating back to 1886• 14 articles • 7 articles translated from Italian and
German• Submitted to Obstetrics & Gynecology
for publication
Findings• 20 cases total• 17 pregnant , 3 postpartum• 9/20 cases reported in the 19th century
• Anthrax reported in 8 countries– 1 in US– Poland, Iran, Iraq, Turkey, India, Italy – Greatest number in Germany
Location Author(Year) # of CasesTurkey Kadalani(2003) 2India Sujatha(2002) 1Poland Tomasiewicz(1998) 1Iran Handjani(1976), Dutz(1971),
Deneshbod (1970), Kohout(1964),
5
U.S. Regan(1923) 1Germany Rostowzew(1897), Eppinger
(1888), Paltauf(1888), Vogt (1927), Marchand (1886)
8
Italy Romano(1888), Morisani(1886)
2
Anthrax by Location
Anthrax Anthrax Form # of
casesSuspected Exposure
Inhalation (3) Unknown
Cutaneous 13 “flaying a dead cow”, “slaughtering a sick cow”, wool sorting, contact with infected “rags”
Gastrointestinal 2 Ingestion of spores, ingestion of improperly cooked beef
Uterine 1 Attempted abortion with contaminated instrument
Unknown 1 “Horse-hair sorting”
Clinical PresentationsCutaneous• Red painless papule black eschar• Significant edema including facial
and neck respiratory compromise• Fever, increased WBC• Enlarged regional lymph nodes• Difficulty swallowing• IUFD, labor
Clinical PresentationsGastrointestinal• Abdominal pain, vomiting, bloody
diarrhea, abdominal bloating, ascites, pallor, hypotension, vaginal bleeding, vulvar edema, anuria
Uterine• Endometritis, massive
hemorrhage, ascites
Case Author Age Gestational Age
Form Maternal Death
Fetal orNeonatal Death
1 Kadalani (2003) 33 32 weeks cutaneous N N
2 Kadalani (2003) 29 33 weeks cutaneous N N
3 Sujatha (2002) 44 NR gastrointestinal
Y Y*
4 Tomasiewicz (1998)
NR 31 weeks cutaneous N N
5 Handjani (1976) 20 16-20 weeks gastrointestinal
Y Y
6 Dutz (1971) NR NR uterine Y Y
7 Kohout (1964) 30 9 months cutaneous Y N
8 Regan (1923) 22 5-6 months cutaneous Y Y9 Rostowzew (1889) 34 8 months cutaneous Y Y
10 Rostowzew (1889) 36 7 months cutaneous Y Y
11 Rostowzew (1897) 35 4 months cutaneous Y Y
12 Eppinger (1888) NR NR (inhalation) Y Y
13 Eppinger (1888) NR NR (inhalation) Y Y
14 Paltauf (1888) NR 5 months (inhalation) Y Y
15 Romano (1888) 20 “full term” cutaneous Y Y
16 Morisani (1886) 40 “full term” cutaneous Y Y
17 Marchand (1886) 32 “full term” Unknown* Y Y
Postpartum CasesCase
Author Age
Time from Delivery ( at Presentation)
Maternal Death
Fetal/Neonatal Death
18 Daneshbod (1970)
NR 3 days Y N
19 Daneshbod (1970)
NR 3 days Y N
20 Vogt (1927) 32 5 months N N
Maternal Outcomes
Maternal Death Proportion = 80%
n=4
Case Year Form Gestational Age
Treatment Fetal Death
3 Sujatha (2002) GI unknown Cefotaximemetronidazole
Y
5 Handjani (1976) GI* 16-20 weeks
Penicillin/Streptomycin Y
6 Dutz (1971) U NR NR Y
7 Kohout (1964) C 9 months* Penicillin N (transient asphyxia)
8 Reagan (1923) C 5-6 months Antiserum in wound, disinfectants
Y
9 Rostowzew (1897)
C 8 months NR Y
10 Rostowzew (1897)
C 7 months NR Y
11 Rostowzew (1897)
C 4 months NR Y
12 Eppinger (1888) (I) NR NR Y13 Eppinger (1888) (I) NR NR Y14 Paltauf (1888) (I) 5 months NR Y
15 Romano (1888) C “full term”* Incision, cautery, disinfectants
N
16 Paltauf (1886) C “close to term”
Cautery Y
17 Marchand (1886) U “full term” NR Y
Fetal/Neonatal Deaths among Pregnancy Cases
Fetal Death Proportion = 64.7%
n=6
n=11
Preterm Deliveries (PTD)Author/Year Anthrax Gestational Age Clinical Kadalani/2003Turkey
Cutaneous(submandible)
32 weeks/34 weeks
Preterm delivery 13 days after presentation and 3 days after “infection resolved” with antibiotics
Kadalani/2003Turkey
Cutaneous (elbow)
33 weeks/34 weeks
Preterm delivery 7 days after presentation despite tocolysis, treated with antibiotics
Tomasiewicz/1998Poland
Cutaneous(eyelid)
31 weeks/34 weeks
Preterm delivery 3 weeks after presentation
Anthrax and Breastfeeding
• Vogt et al. 1927–Maternal case 5 months postpartum– Cutaneous anthrax on hand fever
debridement sepsis – Continued breastfeeding– No evidence of transmission despite
the lack of antibiotic treatment and severe disease
Anthrax in Fetal TissuesAuthor Maternal Anthrax Fetal TissuesRegan (1923) Cutaneous Placenta, amniotic
fluid, lungs, liver, heart
Rostowzew (1897) Cutaneous Placenta, umbilical vessels, liver
Rostowzew (1897) Cutaneous Placenta, umbilical cord liver, spleen, kidneys, adrenals
Rostowzew(1897) Cutaneous Placenta, liver, spleen adrenals
Paltauf (1888) (Inhalation) Placenta, lungs heart
Marchand (1886) Unknown* Blood, lungs, kidneys, adrenals, liver, spleen
Maternal & Neonatal Anthrax32 year old P2 experienced spontaneous labor, resulting in
the delivery of a male infant who appeared healthy at birth. Two hours after delivery, the patient developed weak pulse and lethargy, and experienced 1 episode of vomiting. Her respiratory status rapidly deteriorated and she expired 7 hours after delivery. Maternal autopsy revealed mesenteric edema, ascites and mesenteric lymph glands infiltrated with anthrax bacilli.
On day of life 3, infant developed “blue-red” rash over entire body, lethargy, a bloated abdomen and ultimately respiratory failure. Fetal autopsy revealed “enormous numbers of anthrax bacilli” in fetal blood, liver, spleen, kidneys adrenal glands and lungs.Marchand 1886
Results Summary• 20 cases of naturally-occurring anthrax in pregnant and
postpartum women• Most were cutaneous• High maternal mortality proportion overall and higher than
expected with cutaneous infections• Obstetrical complications
– High fetal/neonatal death proportion– PTD reported – Labor coincided with presentation in 3 cases– Delayed diagnosis may have contributed to disease
severity• Perinatal Transmission
– 6/11 fetal/neonatal deaths demonstrate anthrax in fetal tissues
– No evidence of passage of anthrax via in one case of anthrax sepsis
Limitations
• All naturally-occurring• Very old case reports• Few women received antibiotics• Delays (or failure) to make
diagnosis until autopsy
DiscussionAre pregnant and postpartum women more or less susceptible to anthrax than the
general population?• Unclear from this review
Is anthrax infection more severe in pregnant and postpartum women than in the general population?
• High proportion of maternal deaths but limited antibiotic use• Higher rate of death in cutaneous anthrax than reported for general population
Is there an increased risk of adverse obstetrical outcomes in women infected with anthrax?
• Deliveries- both preterm and full term• High proportion of fetal death
Is there a risk of congenital infection in infants whose mothers are infected with anthrax?
• Evidenced of anthrax in fetal tissues
Is there a risk of anthrax transmission through breast milk?• No evidence to date
Implications• Anthrax has substantial morbidity and
mortality in the obstetrical population • Medical countermeasures for pregnant
and postpartum women – should maximize maternal (and fetal)
survival– may involve the use of medications that are
not typically used this population – may need to include antimicrobials with
transplacental passage
Acknowledgements• Denise Jamieson• Marianne Zotti• Sonya Rasmussen• Tracee Treadwell• Reina Turcios-Ruiz• George Wendel• Sean Shadomy• Deborah Dee• Willie Bower• Etobssie Wako• Mirelys Rodriguez
Animal Data On Anthrax in Pregnancy
• Paucity of data• Reports of increased rates of
spontaneous abortions in cattle (F de Lalla 1992)
• Reports of maternal to fetal transmission in guinea-pigs, dogs, pigs (Regan 1923)
• Reports of anthrax detected in milk from dairy cattle (WHO 1993)
Anthrax in the 1880s• 1829 Regnier describes “anthrax”
transmissibility from mother to fetus• 1855 Pollender discovered bacilli• 1858 Brauell, Davaine & Koch 1867
innoculated pregnant animals--> no fetal infections
• 1882 Strauss/Chamberland & Koubassoff innoculated pregnant animals: fetal infections
• Other studies documenting perinatal transmission in animals– Perroncito, Walley 1889, Simon1889, Malvoz 1888,
Rosenblath 1889, Latis 1891, Lubarsch, Birch-Hirschfeld 1891